# Relates to availability of certain reports detailing sales of opioids in this state

**Bill ID:** S821
**Session:** 2023
**Sponsor:** Pete Harckham
**Status:** Signed by Governor
**PDF:** [S821 PDF](https://legislation.nysenate.gov/pdf/bills/2023/S821)

## Summary

Relates to availability of certain reports detailing sales of opioids in this state; excludes the name, address and DEA registration number of the entity to whom the opioid was sold from such publication.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  821
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  January 6, 2023
  ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
  printed to be committed to the Committee on Rules
 
 AN ACT to amend the tax law, in  relation  to  availability  of  certain
  reports detailing sales of opioids in this state
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Subdivision (g) of section 498 of the tax law,  as  amended
 by  a  chapter  of  the  laws  of  2022 amending the tax law relating to
 requiring the department of health to publish certain reports on depart-
 ment's website detailing sales of opioids sold in the state, as proposed
 in legislative bills numbers S. 7378-A and A. 8339-A, is amended to read
 as follows:
  (g) Each registrant shall provide a report to the department of health
 detailing all opioids sold by such registrant in the state of New  York.
 Such report shall include:
  (i)  the  registrant's  name,  address,  phone  number,  federal  Drug
 Enforcement  Agency  (DEA)  registration  number,  education  department
 registration  number,  and controlled substance license number issued by
 the department of health, if applicable;
  (ii) the name, address and DEA registration number of  the  entity  to
 whom the opioid was sold;
  (iii) the date of the sale of the opioid;
  (iv) the gross receipt total, in dollars, for each opioid sold;
  (v) the name and National Drug Code of the opioid sold;
  (vi)  the number of containers and the strength and metric quantity of
 controlled substance in each container of the opioid sold;
  (vii) the total number of morphine milligram equivalents sold; and
  (viii) any other elements as deemed necessary by the  commissioner  of
 health.
  Such  information  shall  be reported [and published] annually in such
 form as defined by the commissioner of health and shall not  be  subject
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD03968-01-3
 S. 821  2
 
 to  the provisions of section four hundred ninety-nine of this article[,
 with] . WITH the exception of THE INFORMATION COLLECTED UNDER  paragraph
 (ii)  of  this subdivision[.  The], THE DEPARTMENT OF HEALTH SHALL MAKE
 THE  information collected in such [report shall be made] REPORTS avail-
 able to the public in machine-readable formats and [such report shall be
 made] MAKE IT publicly available on the department of  health's  website
 ANNUALLY.
  ยง  2.  This  act  shall  take  effect on the same date and in the same
 manner as a chapter of the laws of 2022 amending the tax law relating to
 requiring the department of health to publish certain reports on depart-
 ment's website detailing sales of opioids sold in the state, as proposed
 in legislative bills numbers S. 7378-A and A. 8339-A, takes effect.